QDEL – QuidelOrtho Corporation
QDEL — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
21.27
Margin Of Safety %
Put/Call OI Ratio
0.96
EPS Next Q Diff
-0.36
EPS Last/This Y
-1.45
EPS This/Next Y
0.65
Price
10.74
Target Price
15
Analyst Recom
3.25
Performance Q
-26.34
Upside
-1,863.0%
Beta
0.81
Ticker: QDEL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-16 | QDEL | 12.9 | 1.01 | 0.48 | 12396 |
| 2026-10-19 | QDEL | 12.76 | 1.04 | 0.00 | 11587 |
| 2026-10-20 | QDEL | 14.23 | 1.03 | 0.01 | 11649 |
| 2026-10-21 | QDEL | 14.09 | 1.00 | 0.01 | 11829 |
| 2026-10-22 | QDEL | 13.47 | 0.99 | 0.33 | 11885 |
| 2026-10-23 | QDEL | 13.72 | 0.99 | 0.00 | 11886 |
| 2026-10-26 | QDEL | 13.76 | 0.99 | 3.17 | 11886 |
| 2026-10-27 | QDEL | 13.58 | 0.99 | 0.27 | 11903 |
| 2026-10-28 | QDEL | 14 | 0.99 | 1.50 | 11924 |
| 2026-10-29 | QDEL | 13.76 | 0.99 | 2.71 | 11926 |
| 2026-10-30 | QDEL | 13.23 | 1.00 | 0.50 | 11977 |
| 2026-11-02 | QDEL | 14.02 | 1.00 | 0.05 | 12005 |
| 2026-11-03 | QDEL | 14.11 | 1.00 | 1.14 | 12010 |
| 2026-11-04 | QDEL | 14.37 | 0.99 | 0.20 | 11970 |
| 2026-11-05 | QDEL | 12.85 | 0.98 | 0.18 | 12034 |
| 2026-11-06 | QDEL | 10.66 | 0.98 | 0.12 | 12065 |
| 2026-11-09 | QDEL | 12.1 | 0.97 | 0.52 | 12129 |
| 2026-11-10 | QDEL | 11.6 | 0.97 | 0.00 | 12174 |
| 2026-11-11 | QDEL | 11.91 | 0.97 | 0.12 | 12169 |
| 2026-11-12 | QDEL | 10.62 | 0.97 | 0.25 | 12149 |
| 2026-11-13 | QDEL | 10.75 | 0.96 | 0.03 | 12049 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-16 | QDEL | 12.91 | -77.6 | - | 0.77 |
| 2026-10-19 | QDEL | 12.76 | -77.7 | - | 0.77 |
| 2026-10-20 | QDEL | 12.76 | -77.7 | - | 0.77 |
| 2026-10-21 | QDEL | 14.23 | -77.7 | - | 0.77 |
| 2026-10-22 | QDEL | 13.48 | -77.7 | - | 0.77 |
| 2026-10-23 | QDEL | 13.73 | -77.7 | - | 0.77 |
| 2026-10-26 | QDEL | 13.77 | -77.7 | - | 0.77 |
| 2026-10-27 | QDEL | 13.58 | -77.7 | - | 0.77 |
| 2026-10-28 | QDEL | 14.01 | -77.7 | - | 0.77 |
| 2026-10-29 | QDEL | 13.76 | -77.7 | - | 0.77 |
| 2026-10-30 | QDEL | 13.23 | -77.7 | - | 0.77 |
| 2026-11-02 | QDEL | 14.03 | -77.7 | - | 0.77 |
| 2026-11-03 | QDEL | 14.12 | -77.7 | - | 0.77 |
| 2026-11-04 | QDEL | 14.37 | -77.7 | - | 0.77 |
| 2026-11-05 | QDEL | 12.85 | -77.7 | - | 0.77 |
| 2026-11-06 | QDEL | 10.68 | 1.9 | - | 0.77 |
| 2026-11-09 | QDEL | 12.09 | 1.9 | - | 0.77 |
| 2026-11-10 | QDEL | 11.53 | 1.9 | - | 0.77 |
| 2026-11-11 | QDEL | 11.92 | 1.9 | - | 0.77 |
| 2026-11-12 | QDEL | 10.61 | 1.9 | - | 0.77 |
| 2026-11-13 | QDEL | 10.74 | -44.6 | - | 0.67 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-16 | QDEL | 0.00 | -9.82 | 22.00 |
| 2026-10-19 | QDEL | 0.00 | -9.94 | 22.00 |
| 2026-10-20 | QDEL | 0.00 | -9.94 | 22.00 |
| 2026-10-21 | QDEL | 0.00 | -9.94 | 22.00 |
| 2026-10-22 | QDEL | 0.00 | -9.94 | 22.00 |
| 2026-10-23 | QDEL | 0.00 | -9.94 | 22.00 |
| 2026-10-26 | QDEL | 0.00 | -10.53 | 22.00 |
| 2026-10-27 | QDEL | 0.00 | -10.53 | 19.12 |
| 2026-10-28 | QDEL | 0.00 | -10.53 | 19.12 |
| 2026-10-29 | QDEL | 0.00 | -10.53 | 19.12 |
| 2026-10-30 | QDEL | 0.00 | -10.53 | 19.12 |
| 2026-11-02 | QDEL | 0.00 | -10.97 | 19.12 |
| 2026-11-03 | QDEL | 0.00 | -10.97 | 19.12 |
| 2026-11-05 | QDEL | 0.00 | -10.97 | 19.12 |
| 2026-11-06 | QDEL | 0.00 | -10.97 | 19.12 |
| 2026-11-09 | QDEL | 0.00 | -9.57 | 19.11 |
| 2026-11-10 | QDEL | 0.00 | -9.57 | 19.11 |
| 2026-11-11 | QDEL | 0.00 | -9.57 | 21.27 |
| 2026-11-12 | QDEL | 0.00 | -9.57 | 21.27 |
| 2026-11-13 | QDEL | 0.00 | -9.57 | 21.27 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.31
Avg. EPS Est. Current Quarter
0.25
Avg. EPS Est. Next Quarter
-0.06
Insider Transactions
Institutional Transactions
-9.57
Beta
0.81
Average Sales Estimate Current Quarter
649
Average Sales Estimate Next Quarter
600
Fair Value
Quality Score
45
Growth Score
33
Sentiment Score
13
Actual DrawDown %
94
Max Drawdown 5-Year %
-94.3
Target Price
15
P/E
Forward P/E
8.17
PEG
P/S
0.28
P/B
0.41
P/Free Cash Flow
EPS
-5.41
Average EPS Est. Cur. Y
0.67
EPS Next Y. (Est.)
1.32
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-14.25
Relative Volume
1.08
Return on Equity vs Sector %
-47
Return on Equity vs Industry %
-31.5
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.11
EBIT Estimation
◆
QDEL
Healthcare
$10.74
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
39
Range 1M
6.8%
Sup Dist
6.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-68.6%
EPS NY
97.7%
52W%
2.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+247.2% upside
Upside
+247.2%
Quality
45
QDEL — P/E HistoricalDiagnostics & Research
QuidelOrtho CorporationSector: Healthcare
Industry: Medical Devices
Employees: 6500
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.
QDEL
Latest News
—
Caricamento notizie per QDEL…
stock quote shares QDEL – QuidelOrtho Corporation Stock Price stock today
news today QDEL – QuidelOrtho Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch QDEL – QuidelOrtho Corporation yahoo finance google finance
stock history QDEL – QuidelOrtho Corporation invest stock market
stock prices QDEL premarket after hours
ticker QDEL fair value insiders trading